REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
Trial
Phase 4
Completed
Dec. 14, 2010
Biofeedback to Ameliorate Freezing of Gait
Trial
N/A
Unknown
Dec. 13, 2010
Reduction of Falls in the Elderly - Parkinson's Disease
Trial
Phase 3
Completed
Nov. 22, 2010
Sensory Attention Focused Exercise in Parkinson's Disease
Trial
N/A
Unknown
Nov. 22, 2010
Visual Selective Attention in Parkinson's Disease
Trial
N/A
Completed
Nov. 21, 2010
Enteric Nervous System in Parkinson's Disease
Trial
N/A
Completed
Nov. 15, 2010
Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease
Trial
N/A
Unknown
Nov. 10, 2010
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Trial
Phase 4
Terminated
Nov. 10, 2010
Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial
Trial
Phase 3
Completed
Nov. 4, 2010
Biofeedback-based Motor Learning to Ameliorate Freezing of Gait
Trial
N/A
Unknown
Oct. 18, 2010
A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
Trial
N/A
Completed
Oct. 17, 2010
Pilot Study of Maintenance Therapy With Intravenous AMANTADINE
Trial
N/A
Unknown
Oct. 12, 2010
Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients
Trial
Phase 1
Terminated
Oct. 5, 2010
Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
Trial
Phase 1
Completed
Oct. 4, 2010
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
Trial
Phase 2
Completed
Sept. 28, 2010
An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.
Trial
Phase 3
Completed
Sept. 12, 2010
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
Trial
Phase 4
Completed
Sept. 7, 2010
Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease
Trial
Phase 3
Completed
Aug. 23, 2010
Levodopa Concentration Profile With Stalevo 75/125 mg
Trial
Phase 1
Completed
Aug. 12, 2010
Glutathione (GSH) In The Treatment of Parkinson's Disease
Trial
Phase 2
Completed
Aug. 8, 2010